Concepedia

Carl C. Ward

CC

Statistics

Publications

16

Citations

3.3K

H-Index

16

Active since

2017

Affiliations

University of California, Berkeley(Current)

Novartis (United States)

Innovative Genomics Institute

Novartis (Switzerland)

University of California, San Francisco

Carl C. Ward is an author at University of California, Berkeley specializing in life sciences, molecular biology, and drug discovery.

ORCID

Publications per year

2017–2024

16

Publications

16

Exogenous Monounsaturated Fatty Acids Promote a Ferroptosis-Resistant Cell State

Leslie Magtanong, Pin‐Joe Ko, Milton To et al. · Cell chemical biology · 2019 · 1.1K citations · Full text

, , +13

Harnessing the anti-cancer natural product nimbolide for targeted protein degradation

Jessica N. Spradlin, Xirui Hu, Carl C. Ward et al. · Nature Chemical Biology · 2019 · 424 citations

, , +17

Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications

Carl C. Ward, Jordan I. Kleinman, Scott M. Brittain et al. · ACS Chemical Biology · 2019 · 336 citations · Full text

, , +16

Deubiquitinase-targeting chimeras for targeted protein stabilization

Nathaniel J. Henning, Lydia Boike, Jessica N. Spradlin et al. · Nature Chemical Biology · 2022 · 321 citations · Full text

, , +10

Improving prime editing with an endogenous small RNA-binding protein

Jun Yan, Paul Oyler, Purnima Ravisankar et al. · Nature · 2024 · 221 citations · Full text

, , +14

1–5 of 16